drugset / Trial / NCT02533973
Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population
RandomizedParallel-groupSingle-blindTreatment
Summary
A phase 4 trial comparing the safety and efficacy of treatment with Xamiol® gel (calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate)) once daily (as required) with Daivonex® scalp solution (calcipotriol 50 mcg/g) twice daily (as required) in Chinese subjects with scalp psoriasis
Timeline
- Start
- 2015-09
- Primary completion
- 2018-03-06
- Completion
- 2018-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Betamethasone | Other / unclassified | 0.5 unknown | Topical |
| Comparator | Calcipotriol | Small molecule | 50 unknown | Topical |